Publicaciones en colaboración con investigadoras/es de GlaxoSmithKline (United Kingdom) (23)

2023

  1. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  2. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

    The Lancet Rheumatology

  3. Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study

    Reumatologia Clinica, Vol. 19, Núm. 6, pp. 312-318

2022

  1. Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

    npj Parkinson's Disease, Vol. 8, Núm. 1

  2. What are the prospects for antiplatelet agents for thromboprophylaxis in antiphospholipid syndrome?

    Expert Review of Clinical Immunology

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2019

  1. Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)

    Parkinsonism and Related Disorders, Vol. 62, pp. 201-209

2015

  1. Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies

    Human Vaccines and Immunotherapeutics, Vol. 11, Núm. 10, pp. 2359-2369

  2. Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease

    Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 1, Núm. 1, pp. 23-36

2013

  1. Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites

    PLoS Medicine, Vol. 10, Núm. 9

2011

  1. Combined haemophilus influenzae type B-neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines

    Pediatric Infectious Disease Journal, Vol. 30, Núm. 11

  2. Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents

    Vaccine, Vol. 29, Núm. 26, pp. 4353-4361

2010

  1. Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months

    Vaccine, Vol. 28, Núm. 36, pp. 5837-5844

2009

  1. Safety and reactogenicity of the 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines

    Pediatric Infectious Disease Journal, Vol. 28, Núm. SUPPL. 4

2003

  1. Facilitating the WHO Expanded Program of Immunization: The clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine

    International Journal of Infectious Diseases, Vol. 7, Núm. 2, pp. 143-151

2000

  1. Immunolocalization of the mGluR1b splice variant of the metabotropic glutamate receptor 1 at parallel fiber-Purkinje cell synapses in the rat cerebellar cortex

    Journal of Neurochemistry, Vol. 74, Núm. 3, pp. 1301-1309

  2. Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: The impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics

    Journal of Antimicrobial Chemotherapy, Vol. 46, Núm. 4, pp. 557-564

1999

  1. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 2, pp. 357-359

  2. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 1, pp. 178-180

1998

  1. Vacuna tetravalente frente a difteria, tetanos, B. pertussis y hepatitis B: Experiencia en Espana

    Anales Espanoles de Pediatria, Vol. 48, Núm. 2, pp. 132-137